세계의 상완골 외측상과염 치료 시장 보고서(2025년)
Lateral Epicondylitis Treatment Global Market Report 2025
상품코드 : 1769638
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

상완골 외측상과염 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.0%로 성장할 전망이며, 28억 4,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 테니스 및 라켓 스포츠 선수 증가, 건설업 및 제조업 등의 분야에서 직업 재해 증가, 가처분 소득의 증가에 의한 치료에 대한 액세스 향상, 물리치료 및 정형외과 클리닉 네트워크 확대, 스포츠 의학 부문의 중요성 고조 등에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 비침습적 치료법 혁신, 재생의료 진보, 로봇 지원 물리치료 개발, 웨어러블 재활기기 이용 확대, AI 지원 진단 및 개별화 치료 접근법 통합 등이 있습니다.

스포츠와 신체 활동에 대한 참여 증가는 상완골 외측상과염 치료 시장의 성장을 가속할 것으로 예측됩니다. 스포츠 및 신체 활동에는 피트니스 향상, 건강 유지, 경쟁 및 레저 추구를 목적으로 한 구조화된 움직임과 레크리에이션적인 움직임이 모두 포함됩니다. 이러한 활동의 증가는 건강의식 고취에 기인한 바가 크며, 질병을 예방하고 전체적인 행복감을 높이기 위해 피트니스를 우선시하는 개인이 증가하고 있습니다. 외측상과염 치료는 통증이 없는 팔의 기능을 회복시킴으로써 이러한 활동을 지원하고 위화감 없이 쥐거나 흔들거나 하는 동작을 가능하게 합니다. 예를 들면, 2024년 2월, 미국의 업계 단체인 스포츠 피트니스 산업 협회(SFIA)는, 2023년에 미국인의 78.8%(2억 4,200만 명)가 적어도 1개의 신체 활동에 임해, 전년부터 2.2% 증가했다고 보고했습니다. 이처럼 스포츠 및 신체활동에 대한 관심이 높아지고 있는 것이 외측상과염 치료 수요에 박차를 가하고 있습니다.

상완골 외측상과염 치료 시장의 주요 기업은 정형외과 질환에 대한 비수술적 선택을 확대하기 위해 혈장 기반 치료와 같은 혁신적인 치료에 점점 더 집중하고 있습니다. 혈장요법은 혈장 속 성분, 특히 성장인자나 항체를 이용해 치유를 촉진하고 조직의 재생을 지원하는 것입니다. 예를 들면, 2023년 12월, 몰디브를 거점으로 하는 고도 의료 시설의 트리탑 병원(TTH)은, 정형 외과 치료의 일환으로서 다혈소판 혈장(PRP) 요법을 도입했습니다. 이 저침습 치료는 외측상과염(테니스 엘보), 초기 단계의 무릎 관절염, 스포츠 관련 힘줄 손상 등의 근골격계 질환을 대상으로 하고 있습니다. TTH는 PRP 요법을 도입함으로써 신체의 자연 치유 메커니즘을 이용해 회복 성과를 높이고 외과적 처치에 대한 의존을 줄이며 에비던스에 기반한 재생 솔루션을 환자에게 제공하는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Lateral epicondylitis treatment encompasses various clinical interventions designed to alleviate pain, reduce inflammation, and promote healing in individuals affected by lateral epicondylitis-a condition resulting from overuse or strain of the forearm tendons. The goal of treatment is to restore normal arm function, improve mobility and strength, and facilitate a return to daily or occupational activities without symptom recurrence.

The primary treatment types include non-surgical and surgical options. Non-surgical treatments involve conservative approaches such as physical therapy, bracing, medications, and regenerative therapies like platelet-rich plasma (PRP) to manage symptoms and restore function without surgery. These treatments cater to different age groups, including pediatric, adult, and geriatric populations, and are applied in contexts such as athletic and general use. Treatment is delivered across various settings, including hospitals, ambulatory surgical centers, orthopedic clinics, homecare environments, and other healthcare facilities.

The lateral epicondylitis treatment market research report is one of a series of new reports from The Business Research Company that provides lateral epicondylitis treatment market statistics, including lateral epicondylitis treatment industry global market size, regional shares, competitors with a lateral epicondylitis treatment market share, detailed lateral epicondylitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the lateral epicondylitis treatment industry. This lateral epicondylitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral epicondylitis treatment market size has grown strongly in recent years. It will grow from $2.22 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to several factors, including the rising prevalence of lateral epicondylitis, an aging population increasingly susceptible to musculoskeletal disorders, a higher incidence of the condition among athletes and manual laborers, greater awareness of repetitive strain injuries, and the impact of sedentary urban lifestyles that contribute to joint and muscle strain.

The lateral epicondylitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to the increasing number of tennis and racquet sports players, a rise in occupational hazards in sectors like construction and manufacturing, higher disposable incomes facilitating better access to treatment, the expansion of physical therapy and orthopedic clinic networks, and the growing significance of sports medicine departments. Key trends expected during this period include innovations in non-invasive treatment methods, advancements in regenerative medicine, the development of robotic-assisted physiotherapy, the growing use of wearable rehabilitation devices, and the integration of AI-assisted diagnostics and personalized treatment approaches.

The increasing participation in sports and physical activities is expected to drive growth in the lateral epicondylitis treatment market. Sports and physical activities encompass both structured and recreational movements aimed at improving fitness, maintaining health, or engaging in competitive or leisure pursuits. This rise in activity is largely driven by growing health awareness, as more individuals prioritize physical fitness to prevent illness and enhance overall well-being. Lateral epicondylitis treatment supports these activities by restoring pain-free arm function, enabling actions such as gripping and swinging without discomfort. For example, in February 2024, the Sports and Fitness Industry Association (SFIA), a US-based trade association, reported that 78.8% of Americans-or 242 million people-engaged in at least one physical activity in 2023, marking a 2.2% increase from the previous year. Thus, the rising engagement in sports and physical activities is fueling the demand for lateral epicondylitis treatment.

Major companies in the lateral epicondylitis treatment market are increasingly focusing on innovative therapies, such as plasma-based treatments, to expand non-surgical options for orthopedic conditions. Plasma therapies utilize components of blood plasma-especially growth factors or antibodies-to accelerate healing and support tissue regeneration. For example, in December 2023, Tree Top Hospital (TTH), a Maldives-based advanced healthcare facility, introduced platelet-rich plasma (PRP) therapy as part of its orthopedic care offerings. This minimally invasive treatment targets musculoskeletal conditions including lateral epicondylitis (tennis elbow), early-stage knee arthritis, and sports-related tendon injuries. By incorporating PRP therapy, TTH aims to enhance recovery outcomes using the body's natural healing mechanisms, reducing reliance on surgical procedures and offering patients an evidence-based, regenerative solution.

In March 2023, TendoNova, a US-based provider of lateral epicondylitis treatment solutions, partnered with AcCELLerated Biologics LLC to expand market reach and enhance clinical capabilities. This strategic collaboration aims to integrate TendoNova's micro-invasive tendon treatment technologies with AcCELLerated Biologics' biologic therapies, offering a comprehensive approach to managing chronic tendon disorders. By aligning device innovation with biologic solutions, the partnership seeks to broaden physician access and improve patient outcomes in the treatment of conditions such as lateral epicondylitis. AcCELLerated Biologics LLC is a US-based supplier of biologic products used in orthopedic and regenerative treatments.

Major players in the lateral epicondylitis treatment market are Merck & Co. Inc., 3M Company, Mayo Foundation for Medical Education and Research (MFMER), Cleveland Clinic, Chugai Pharmaceutical, Johns Hopkins Medicine, MedStar Health, Cipla Inc., Enovis Corporation, OttoBock HealthCare, Ossur Corporate, Max Healthcare, Seikagaku Corporation, Texas Orthopedic Specialists, Johari Digital, Mediheal Group of Hospitals, Scandinavian Physiotherapy Center, Veritas Health LLC, Folsom Orthopaedics & Sports Medicine, ReLiva Physiotherapy & Rehab, Molecular Pharmacology Limited.

North America was the largest region in the lateral epicondylitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lateral epicondylitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lateral epicondylitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lateral epicondylitis treatment market consists of revenues earned by entities by providing services such as outpatient musculoskeletal physiotherapy sessions, telehealth consultations for elbow pain, occupational therapy programs, post-surgical recovery and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The lateral epicondylitis treatment market also includes sales of platelet-rich plasma (PRP) kits, extracorporeal shock wave therapy (ESWT) devices, ultrasound therapy equipment, elbow support braces with biofeedback sensors, and topical anti-inflammatory gels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Epicondylitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral epicondylitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lateral epicondylitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lateral epicondylitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Lateral Epicondylitis Treatment Market Characteristics

3. Lateral Epicondylitis Treatment Market Trends And Strategies

4. Lateral Epicondylitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lateral Epicondylitis Treatment Growth Analysis And Strategic Analysis Framework

6. Lateral Epicondylitis Treatment Market Segmentation

7. Lateral Epicondylitis Treatment Market Regional And Country Analysis

8. Asia-Pacific Lateral Epicondylitis Treatment Market

9. China Lateral Epicondylitis Treatment Market

10. India Lateral Epicondylitis Treatment Market

11. Japan Lateral Epicondylitis Treatment Market

12. Australia Lateral Epicondylitis Treatment Market

13. Indonesia Lateral Epicondylitis Treatment Market

14. South Korea Lateral Epicondylitis Treatment Market

15. Western Europe Lateral Epicondylitis Treatment Market

16. UK Lateral Epicondylitis Treatment Market

17. Germany Lateral Epicondylitis Treatment Market

18. France Lateral Epicondylitis Treatment Market

19. Italy Lateral Epicondylitis Treatment Market

20. Spain Lateral Epicondylitis Treatment Market

21. Eastern Europe Lateral Epicondylitis Treatment Market

22. Russia Lateral Epicondylitis Treatment Market

23. North America Lateral Epicondylitis Treatment Market

24. USA Lateral Epicondylitis Treatment Market

25. Canada Lateral Epicondylitis Treatment Market

26. South America Lateral Epicondylitis Treatment Market

27. Brazil Lateral Epicondylitis Treatment Market

28. Middle East Lateral Epicondylitis Treatment Market

29. Africa Lateral Epicondylitis Treatment Market

30. Lateral Epicondylitis Treatment Market Competitive Landscape And Company Profiles

31. Lateral Epicondylitis Treatment Market Other Major And Innovative Companies

32. Global Lateral Epicondylitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lateral Epicondylitis Treatment Market

34. Recent Developments In The Lateral Epicondylitis Treatment Market

35. Lateral Epicondylitis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기